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Abstract: Background: Dietary intake of natural antioxidants is thought to impart protection against
oxidative-associated cardiovascular diseases. Despite many in vivo studies and clinical trials, this
issue has not been conclusively resolved. Resveratrol (RES) is one of the most extensively studied
dietary polyphenolic antioxidants. Paradoxically, we have previously demonstrated that high RES
concentrations exert a pro-oxidant effect eventually elevating ROS levels leading to cell death.
Here, we further elucidate the molecular determinants underpinning RES-induced oxidative cell
death. Methods: Using human umbilical vein endothelial cells (HUVECs), the effect of increasing
concentrations of RES on DNA synthesis and apoptosis was studied. In addition, mRNA and protein
levels of cell survival or apoptosis genes, as well as protein kinase C (PKC) activity were determined.
Results: While high concentrations of RES reduce PKC activity, inhibit DNA synthesis and induce
apoptosis, low RES concentrations elicit an opposite effect. This biphasic concentration-dependent
effect (BCDE) of RES on PKC activity is mirrored at the molecular level. Indeed, high RES
concentrations upregulate the proapoptotic Bax, while downregulating the antiapoptotic Bcl-2,
at both mRNA and protein levels. Similarly, high RES concentrations downregulate the cell cycle
progression genes, c-myc, ornithine decarboxylase (ODC) and cyclin D1 protein levels, while low RES
concentrations display an increasing trend. The BCDE of RES on PKC activity is abrogated by the ROS
scavenger Tempol, indicating that this enzyme acts downstream of the RES-elicited ROS signaling.
The RES-induced BCDE on HUVEC cell cycle machinery was also blunted by the flavin inhibitor
diphenyleneiodonium (DPI), implicating flavin oxidase-generated ROS as the mechanistic link in the
cellular response to different RES concentrations. Finally, PKC inhibition abrogates the BCDE elicited
by RES on both cell cycle progression and pro-apoptotic gene expression in HUVECs, mechanistically
implicating PKC in the cellular response to different RES concentrations. Conclusions: Our results
provide new molecular insight into the impact of RES on endothelial function/dysfunction, further
confirming that obtaining an optimal benefit of RES is concentration-dependent. Importantly, the
BCDE of RES could explain why other studies failed to establish the cardio-protective effects mediated
by natural antioxidants, thus providing a guide for future investigation looking at cardio-protection
by natural antioxidants.
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1. Introduction
Reactive oxygen species (ROS) are byproducts of regular aerobic metabolism. Although widely
recognized as harmful entities, depending on their concentration, ROS may exert different effects on
cell physiology. ROS levels produced under physiological conditions are the result of well-orchestrated
balancing activities of ROS-generating enzymes and endogenous antioxidant mechanisms. These ROS
level balancing activities modulate several signalling cascades implicated in normal physiological
responses [1]. On the other hand, when the above-mentioned balance is lost, the levels of ROS
increase dramatically, and a state of oxidative stress is established causing damage to cellular structures
and internal components [2,3]. Consequently, ROS plays a critical role in both physiological and
pathophysiological processes [4].
Redox-regulated signalling pathways are common ROS-mediated signal transduction mechanisms
widely adopted by the cells [5]. ROS can modulate several signalling cascades implicated in a myriad
of cellular processes such as proliferation, differentiation, or apoptosis [6]. However, the exact
mechanism of these ROS-mediated events is not fully understood. Studies have demonstrated that
ROS activates receptor tyrosine kinases (RTK) such as the epidermal growth factor receptor (EGFR)
and platelet-derived growth factor receptor (PDGFR), as well as their downstream kinases including
PI3K/Akt and MAPK/ERK pathways leading to cell proliferation, nutrient uptake, and cell survival [7].
ROS can also activate several other kinases such as Protein Kinases C (PKCs), Protein Kinases G (PKGs),
c-Jun N-terminal kinases (JNKs), p38 mitogen-activated protein kinases (p38 MAPKs) [8], and many
more [9].
Disease-associated oxidative stress, due to the failure of the cell to maintain its redox homeostasis,
may ultimately trigger unwanted cellular responses including programmed cell death or apoptosis [10].
Several genes and proteins including essential regulators of cell proliferation such as c-myc, ornithine
decarboxylase (ODC), and PKC are affected during the above-mentioned processes [11–17]. ODC and
c-myc play important roles in anabolic metabolism, DNA synthesis, regulation of gene expression,
anti-differentiation, and cell growth [18–23]. ODC is involved in G1/S, S/G2, and G2/M cell cycle
transitions [24]. On the other hand, c-myc plays a critical role in G0/S transition during the cell cycle
progression. Downregulation of c-myc affects mitochondrial function, glycolysis and proliferation
of endothelial cells, while its overexpression activates ODC which then promotes cell growth [25].
Importantly, ODC levels are tightly regulated as it is a potential oncogene whose overexpression
contributes to cellular transformation by other oncogenes [26].
PKCs are serine/threonine kinases and belong to a protein family that encompasses 3 subfamilies:
conventional PKCs, novel PKCs, and atypical PKCs. ROS covalently modify PKCs at their cysteine-rich
zinc finger domain leading to their activation [27]. Interestingly, PKC activation can induce
NADPH-oxidases (NOX) activity which further exacerbates ROS production [28]. Moreover, PKC
activation is associated with cell survival and apoptosis, angiogenesis, extracellular matrix deposition,
and contractility of vascular smooth muscle cells [17,29]. For instance, Wang et al. recently demonstrated
that ROS-mediated apoptosis in cultured primary cardiomyocytes occurs through the activation of
PKCβ [30]. This bidirectionality in PKC and NOX activation could have implications for cellular injury
in various pathologies [31].
Endothelial cells (ECs) are crucial for the maintenance of cardiovascular homeostasis. Indeed,
endothelial dysfunction is a critical step in the onset and progression of many cardiovascular diseases
(CVDs) including atherosclerosis and hypertension [32,33]. Both the integrity and functions of the
endothelial layer are greatly affected by ROS [34]. Furthermore, the interplay between ROS and PKC
in endothelial function is well-established. For instance, overexpression of PKC increases intercellular
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adhesion molecule-1 expression, a pro-inflammatory protein, via ROS [35]. Moreover, PKC-mediated
endothelial dysfunction involves both NOX and ROS production [36].
Dietary natural polyphenols such as those found in vegetables, tea, or coffee possess strong
antioxidant capacities, and it is widely accepted that their consumption could preserve ECs function
eventually reducing CVDs occurrence [37]. One of the most commonly consumed and studied
polyphenols is resveratrol (RES). RES is a natural polyphenolic compound present in grapes, peanuts
and some berries [38–40]. By virtue of its ability to reduce oxidative stress, cardiovascular protective
effects of RES were proposed and later established in several in vitro, ex vivo, and animal studies [39,41].
However, the so far available clinical trials on humans have provided controversial results concerning
the protective effects of RES against CVDs and its sequelae [42,43].
Several studies suggest that only lower concentrations of RES exert beneficial effects on ECs [44].
A biphasic concentration effect of RES has also been reported in angiogenesis assays [45]. Moreover,
we and others have shown that high concentrations of RES increase rather than decrease ROS
production [43,46–49]. More importantly, at high concentrations, RES acts as a xenobiotic compound
whose metabolism produces elevated levels of ROS leading to cellular apoptosis. We have postulated
that this ROS-mediated damage is through cytochrome P450, CYP2C9, metabolism of RES that produces
excessive ROS which downregulates Akt—a key player in cell proliferation [43,46]. This observation
is in contrast with the mainstream notion that increasing RES consumption will lead to more ROS
scavenging and hence more cytoprotection.
Determining the optimal cytoprotective dose of RES has been hampered by the lack of a complete
understanding of the molecular mechanisms underlying RES-induced pro-survival and pro-apoptotic
effects. Therefore, with the aim of further dissecting the molecular basis of RES impact on EC
homeostasis, here we assessed the expression of a series of genes (either at the mRNA or protein levels)
involved in the regulation of cell survival and apoptosis such as c-myc, ODC, Bcl-2, Bax, and Cyclin
D1. Moreover, based on the rational proposed in the introduction we also investigated (1) whether
the potential bidirectionality between ROS and PKC is implicated in the biphasic response elicited
by RES on ECs function, and (2) whether the assessed genes may be mechanistically involved in the
above-hypothesized phenomenon.
2. Materials and Methods
Unless otherwise specified, all chemicals were purchased from Sigma (Sigma St. Louis, MO, USA)
2.1. Cell Culture and Treatment
Human umbilical vein endothelial cells (HUVECs) were obtained from Cell Applications (Cell
Applications, San Diego, CA, USA) and cultured as previously described [43]. HUVECs were
sub-cultured at a split ratio of 1:2 and used within three passages before cell viability was checked
using trypan blue. Unless not otherwise specified, cells were plated in 96-well black plates (BD Falcon,
Franklin Lakes, NJ) and processed for experiments in Medium M199 containing 5% FCS plus the
different treatments. RES 10 mM stock solution was prepared in dimethyl sulfoxide (DMSO); final
DMSO concentration in the diluted treatment media was less than 0.1%. DMSO (less than 0.1%)
was used as a vehicle control. To investigate the involvement of ROS and NADPH oxidase in the
RES-induced cellular effects, in selected experiments, cells were pretreated for 1 h with either 100 µM of
the broad antioxidant Tempol [50] or with 10µM of the flavin-oxidase inhibitor Diphenyleneiodonium
(DPI) [49,51,52]. The involvement of PKC in HUVECs response to RES treatment was investigated by
using 2.5 µM of the broad PKC inhibitor chelerythrine (CHE) [53,54].
2.2. Measurement of Intracellular ROS
Intracellular ROS levels were assessed using the molecular probe 2′,7′-dichlorodihydrofluorescein
diacetate ([H2DCF-DA]; Molecular Probe, Eugene, OR, USA), as previously described [55,56]. Within
the cell, esterases cleave the acetate groups on H2DCF-DA, thus trapping the reduced form of the
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probe (H2DCF). Intracellular ROS oxidize H2DCF, yielding the fluorescent product, DCF. After
treatments, cells were incubated for 30 min with Hanks′ Balanced Salt Solution (HBSS) containing
10 µM H2DCF-DA, then washed twice with HBSS and fluorescence was measured by using a GENios
plus micro-plate reader (Tecan, Männedorf, CH). Excitation and emission wavelengths used for
fluorescence quantification were 485 nm and 535 nm, respectively. All fluorescence measurements
were corrected for background fluorescence and protein concentration. Using untreated cells as a
reference, the anti- and pro-oxidant outcome was evaluated by comparison of five measurements and
expressed as a percentage of untreated controls.
2.3. Determination of the Intracellular Redox State
The intracellular redox state was investigated by using the lentiviral vector encoding for the
redox-sensing green fluorescent protein (roGFP), which reports the redox state of the GSH/GSSG
pool in vivo in both plant and mammalian cells [57–59]. The procedure was performed as previously
described [46,59,60]. Three days after virus infection, cultured cells showed a transduction efficiency
of about 70% as depicted by Figure 1A, which is representative of six photos taken with a fluorescence
microscope (Olympus XI70). roGFP has two fluorescence excitation maxima at 400 (oxidized form)
and 485 nm (reduced form) and displays rapid and reversible ratiometric changes in fluorescence in
response to changes in ambient redox potential and therefore the ratios of fluorescence from excitation
at 400 and 485 nm indicate the extent of oxidation [58]. In place of confocal imaging analysis, we
used a developed fluorometer-based method for monitoring roGFP oxidation [46,59–61]. Fluorescence
measurements were performed in clear 24-well plates (Corning, Lowell, MA, USA) on a fluorescence
plate reader GENios plus (Tecan, Männedorf, Zürich, Switzerland) from the upper side using multiple
reads per well (the read pattern was square, and the number of reads was 2 x 2). Cells were excited
using 400 and 485 nm filters, and fluorescence values were measured using a 535 nm emission filter.
For background correction, emission intensities were determined for non-transformed cells (4 discs
each experiment) exposed to the same excitation wavelengths under the same conditions. These
values were averaged and subtracted from the fluorescence values of roGFP. The degree of oxidation
of the roGFP was estimated from the ratios of light intensities obtained measuring 1-min intervals
under 400 and 485 nm excitation. Treatment-induced variations of roGFP oxidation were estimated by
comparison with roGFP oxidation in control untreated cells.
2.4. Determination of Cell Viability
Cell viability was assessed in 96-well plates (BD Falcon) by using the colorimetric
3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide (MTT reagent) assay (Promega, Madison,
WI, USA) [51,62]. Yellow MTT reagent enters the cells and passes into the mitochondria where
mitochondrial dehydrogenases of viable cells cleave the tetrazolium ring, yielding a reduced purple
MTT formazan crystals which are insoluble in aqueous solutions. This reduction occurs only when
mitochondrial enzymes are active, and therefore conversion can be directly related to the number of
viable cells. The formazan crystals can be dissolved in acidified isopropanol. The resulting purple
solution is spectrophotometrically measured at 570 nm. An increase in cell number results in a large
amount of MTT formazan formed and an increase in absorbance at 570 nm. After 24 h of RES treatment,
20 µl of MTT solution (2 mg/mL) in medium M199 were added to the cells and incubated at 37 ◦C in a
cell culture incubator for 2 h. At the end of the incubation period, the solution was removed, and the
purple formazan product was solubilized with acidic isopropanol (0.04 N HCl in absolute isopropanol).
Then plates were analyzed at 570 nm using a GENios plus micro-plate reader (Tecan). Results are
expressed as a percent of untreated control cells.
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Figure 1. Concentration-dependent effect of resveratrol on HUVECs intracellular ROS levels and redox
state. (A) Human umbilical vein endothelial cells (HUVECs) expressing the cytoplasmatic form of
the redox-sensing green fluorescent protein (roGFP) were treated for 6 hrs in M199 medium with 5%
FCS containing different concentrations of resveratrol (RES) as indicated. After treatment, cells were
washed with PBS three times, fixed with 4% paraformaldehyde, counterstained with Hoechst, mounted
and visualized by fluorescence microscopy. Images depict cytoplasmic merged photos of roGFP
(green) and nuclear Hoechst staining (blue) of cells at 100X magnification. (B) HUVECs expressing
the cytoplasmatic form of the roGFP were treated for 24 hrs with the indicated concentrations of
resveratrol and then analyzed for the variation of the intracellular redox state as described in materials
and methods. (C) HUVECs loaded with the ROS probe H2DCF-DA were treated for 6 hrs with the
indicated concentrations of resveratrol then ROS levels were assessed as described in materials and
methods. ctrl: untreated cells; and RFU: relative fluorescence units. Means ± SD of a representative
experiment, performed in triplicates, are shown. *, significantly different from the control (p < 0.01).
2.5. Determination of DNA Synthesis
DNA synthesis was assessed by using a chemiluminescent immunoassay method, which is based
on the measurement of BrdU incorporation during DNA synthesis (Cell Proliferation ELISA BrdU,
Roche Applied Science). When cells are pulsed with BrdU, it is incorporated into newly synthesized
DNA strands of actively proliferating cells. The incorporation of BrdU into cellular DNA can be
detected using anti-BrdU antibodies, allowing assessment of the population of cells synthesizing DNA.
Subconfluent HUVECs were treated for 24 hrs as indicated in the figure legends, and BrdU was added
12 hrs before the end of the experiments. After that, the culture supernatant was removed, and the cells
were fixed with a Fix-Denat solution for 30 min. The Fix-Denat was discarded, and cells were incubated
with an anti-BrdU antibody conjugated to horseradish peroxidase for 90 min. After rinsing three times
with washing buffer, a peroxidase substrate solution was added and allowed to react for 3–10 min at
room temperature. The horseradish peroxidase catalyzes the oxidation of diacyl hydrazide, where the
reaction product decay from its excited state yields light. Finally, light emission was read by using a
GENios Plus microplate reader (Tecan). Results were normalized for protein content and expressed as
the mean ± SD of the relative fluorescence units (RFU) values [51,52,63]. Data are representative of
three independent experiments and are shown as percent of untreated control cells.
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2.6. Immunoblot Analysis
Immunoblotting analysis was performed as previously described [43,64,65]. Experiments were
performed with subconfluent HUVECs in a T-25 culture flask (Falcon, Oxnard, CA, USA). After 12 hrs
of RES treatment, the medium was removed, and cells were detached with 0.1% trypsin plus 0.02%
EDTA in PBS, pH 7.3 and pelleted by centrifugation at 1,000x g for 5 min. The pellet was washed
with PBS, centrifuged as above and then resuspended in 100 µl of a chilled lysis buffer (50 mM Hepes,
pH 7.5, 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 1 mM sodium vanadate, 50 mM
sodium fluoride, 20 mM β-glycerophosphate, 0.1 mM okadaic acid, 1 mM phenylmethylsulfonyl
fluoride, 20 mg/mL aprotinin, 50 mg/mL leupeptin, and 10 mM pepstatin). The samples were sonicated
for 10 s (Branson, sonifer B-12, setting3) and incubated at 4 ◦C for 15 min, lysates were then centrifuged
at 10,000× g for 15 min (4 ◦C) and analyzed for the protein content by Lowry method. Each sample
was mixed with Laemmli sample buffer and boiled for 4 min. Equal amounts of proteins (10 to
20 µg/lane) were loaded. Sample and pre-stained molecular weight markers (Santa Cruz Biotechnology,
Inc. Santa Cruz, CA, USA) were separated on 10% SDS-PAGE gel. Proteins were transferred to a
nitrocellulose membrane in buffer containing 25 mM Tris-HCl, 192 mM glycine, and 20% methanol for
2 h at 350 mA at room temperature. Following transfer, nitrocellulose membranes were incubated for
1 h in 20 mM Tris-HCl, pH 7.6, 137 mM NaCl, 0.2% Tween 20 (TNT 20) with 5% non-fat dried milk,
washed three-times in TNT 20 (3, 3, 5 min), and incubated for 1 h with primary antibody in TNT 20
containing 5% milk at room temperature. Cyclin D1, c-myc, and Bcl-2 proteins were detected using
specific primary antibodies (Cell Signaling, Danvers, MA, USA). After further washing in TNT 20,
membranes were incubated for 1 h with horseradish peroxidase-linked anti-IgG secondary antibody
diluted 1:5000 (Bio-Rad, Hercules, CA, USA) and immunoreactive proteins were detected by ECL as
described by the supplier (Amersham Pharmacia Biotech, Buckinghamshire, U.K). The intensities of
bands were measured by using a Versadoc Imaging System (Bio-Rad). Band intensity was expressed as
relative immunodensity units. The ratio between bands intensities of the loading control (β-actin) and
the proteins of interest was calculated to normalize for potential variations in protein loading. Mean,
and standard deviation, of four performed experiments was expressed as Relative immunodensity and
was calculated after normalization to β-actin. Data are expressed as the mean ± SD.
2.7. Determination of DNA Fragmentation
Experiments were performed in T-25 culture flasks (Falcon, Oxnard, CA, USA) with subconfluent
HUVECs. After RES treatment, the medium was removed, and cells were detached with 0.1% trypsin
plus 0.02% EDTA in PBS, pH 7.3 and pelleted by centrifugation at 1,000x g for 5 min. The pellet was
washed with PBS, centrifuged as above and then resuspended in 500 µl of detergent buffer (10 mM Tris
[pH 7.4], 5 mM EDTA, 0.2% Triton). Pellet was vortexed for 2 min, incubated on ice for 30 min and
then centrifugated at 27,000x g for 30 min. The supernatant was divided into two 250 µL aliquots, and
50 µL of ice-cold 5 M NaCl was added to each aliquot and the vortexed again. DNA was precipitated
by adding 600 µL ethanol plus 150 µL 3 M sodium acetate at pH 5.2; then the solution was mixed by
pipetting up and down. Tubes were incubated at −80 ◦C for 1 h. DNA was pelleted by 20 min of
centrifugation at 20,000x g. After having carefully discarded the supernatant, DNA from different
aliquots was pooled by re-dissolving the two pellets in a total of 400 µL extraction buffer (10 mM Tris
and 5 mM EDTA). Two µL of 10 mg/mL DNase-free RNase was added, and samples were incubated for
5 h at 37 ◦C. Twenty-five µL proteinase K (20 mg/mL) and 40 µL of buffer (100 mM Tris pH 8.0, 100 mM
EDTA, 250 mM NaCl) were added before incubating the sample overnight at 65 ◦C. DNA was extracted
with phenol/chloroform/isoamyl alcohol (25:24:1) and precipitated with ethanol. After having carefully
discarded the supernatant, the pellet was air-dried and resuspended in 20 µL Tris-acetate EDTA buffer
supplemented with 2 µL of sample buffer (0.25% bromophenol blue, 30% glycerol). Then the DNA
samples were separated electrophoretically on a 2% agarose gel containing 1 µg/mL ethidium bromide
and visualized by ultraviolet transillumination. Band intensity was expressed as relative absorbance
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units. Intensities of the gel bands were measured by using a Versadoc Imaging System (Bio-Rad) and
results were expressed as a percent of untreated control cells. [66–68]
2.8. Cell Cycle Analysis
Cell Cycle progression was monitored by quantification of cellular DNA content using the
Tali® Cell Cycle kit (Invitrogen) [69]. The analysis was performed according to the manufacturer′s
instructions. Briefly, HUVECs were seeded at a density of 0.6 × 106 cells/mL in 6-multiwell plate and
treated with RES for 48 h. After harvesting by trypsinization, cells were rinsed with PBS then fixed in
ice-cold 70% ethanol at −20 ◦C overnight. Following the centrifugation at 1,000x g for 5 min, cells were
resuspended in PBS and centrifuged again at 500x g for 10 min. Cells were then stained in Tali® Cell
Cycle Solution (containing propidium iodide, RNase A, and Triton® X-100) for 30-min, in the dark
at RT. Data were analyzed using the Tali® Image-Based Cytometer (Invitrogen) and the percentage
of cells in each phase of cell cycle was determined using FACS Express Research Edition software
(version 4.03; De Novo Software, NJ, USA) [70].
2.9. Semi-Quantitative Reverse Transcription-Polymerase Chain Reaction (RT-PCR)
RT-PCR: Experiments were performed in a T-25 culture flask (Falcon, Oxnard, CA, U.S.A.) with
confluence contact-dependent growth inhibited cells. After 12 hrs of RES treatment, total RNA was
extracted, reverse transcribed and amplified according to the procedure previously described [71–73].
One µg of total RNA from human endothelial cells was reverse-transcribed for 45 min at 37 ◦C. The
reaction was performed in a solution of 25 µl containing, 50 mM Tris-HCl pH 8.3, 75 mM KCl, 3 mM
MgCl2, 10 mM dithiothreitol (DTT), 0.2 mM of each dNTP, 0.1 µg of oligo dT, 200 units of M-MLV
reverse transcriptase (Thermo Fisher Scientific, Waltham, Massachusetts, USA). The reaction mixture
was then heated at 95 ◦C for 5 min to inactivate the enzyme. PCR amplification was performed in
25 µl of a reaction mixture containing: 5 µl of the reverse transcribed cDNA, 20 mM Tris-HCl pH 8.3,
50 mM KCl, 1.5 mM MgCl2, 2.5 units of Taq polymerase (Thermo Fisher Scientific), 0.2 mM of each
dNTP, and 50 pmoles of each forward and reverse primer that had previously dissolved in TE solution
(Tris 10 mM pH 8.0, EDTA 1 mM pH 8.0). Primers for ODC, Bax, Bcl-2, c-myc, and GAPDH were
designed using Primer 3 software and optimized in the laboratory. Primers sequences were: Forward,
5′-CCACCCATGGCAAATTCCATGGCA-3′, reverse 5′-TCTAGACGGCAGGTCAGGTCCACC-3′ for
GADPH; Forward,5′-TACCCTCTCAACGACAGCAGCTCGCCCAACTCCT-3′, Reverse,5′-TCTTG
ACATTCTCCTCGGTGTCCGAGGACCT-3′ for c-myc; Forward,5′-GCAGGATCCACCATGAACAAC
TTTGGTAA-3′, Reverse,5′-GCCGAGATCTCAGAAGAAGAAACTTC-3′ for ODC; Forward, 5′-CCTTT
TCTACTTTGCCAGCAAAC-3′, Reverse, 5′-GAGGCCGTCCCAACCAC-3′ for BAX; Forward,
5′-AGGGTCAGATGGACACATGGTG-3′, Reverse, 5′-CGTTGCCTGTGGGTGACTAATC-3′. Bcl-2.
ODC and GAPDH were amplified in 30 cycles (ODC: 72 ◦C for 60 s, 95 ◦C for 40 s, 43 ◦C for 40 s;
GAPDH: 95 ◦C for 30 s, 58 ◦C for 30 s, 72 ◦C for 1 min); while Bax and c-myc were amplified in 35 cycles
(Bax: 95 ◦C for 45 s, 60 ◦C for 50 s, 72 ◦C for 60 s; c-myc: 72 ◦C for 60 s, 95 ◦C for 40 s, 60 ◦C for 40 s); Bcl-2
was amplified in 38 cycles (95 ◦C for 45 s, 68 ◦C for 50 s, 72 ◦C for 60 s). The number of amplification
cycles was determined experimentally for each primer pair and to find out the exponential phase of
amplification, different PCR cycles from 15 to 50 were tested. Using 30 PCR cycles, all the PCR products
were within the linear phase of the reaction. Similar conditions have been previously reported for
semiquantitative analysis of gene expression [71–73].
Gel Electrophoresis: The PCR products were loaded onto Ethidium Bromide stained 1% agarose
gels in TBE. A 1 kbp DNA ladder molecular weight marker (Gibco BRL, Paisley, U.K) was run on every
gel to confirm the expected molecular weight of the amplification product. GAPDH was used for each
sample as an internal control for mRNA integrity and equal loading.
Acquisition of gel images and quantitative analysis: Images of the RT-PCR ethidium
bromide-stained agarose gels were acquired and densitometrically analyzed by using the Versadoc
Imaging System (Bio-Rad). Band intensity was expressed as relative absorbance units. The ratio
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between the specific gene and GAPDH was calculated to normalize to initial variations in sample
concentration and as a control for reaction efficiency. Mean and standard deviation of all experiments
performed was calculated after normalization to GAPDH [71–73].
2.10. Determination of PKC Activity
HUVECs cultured in T-25 culture flasks (Falcon) were treated with RES for 40 min, then cells were
processed as previously described [65]. After RES treatment, the medium was removed, and cells
were detached with 0.1% trypsin plus 0.02% EDTA in PBS, pH 7.3 and pelleted by centrifugation, at
1000× g for 5 min. The pellet was washed with PBS, centrifuged and then resuspended in 100 µl of a
chilled lysis buffer (50 mM HEPES, pH 7.5, 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate,
1 mM sodium vanadate, 50 mM sodium fluoride, 20 mM β-glycerophosphate, 0.1 mM okadaic acid,
1 mM phenylmethylsulfonyl fluoride, 20 mg/mL aprotinin, 50 mg/mL leupeptin, and 10 mM pepstatin).
Samples were sonicated for 10 s (Branson, sonifer B-12, setting3) and incubated at 4 ◦C for 15 min;
lysates were then centrifuged at 10,000× g for 15 min (4 ◦C) and analyzed for the protein content by
Lowry method. Aliquots of the homogenate were taken to measure total PKC activity by a PKC enzyme
assay system (PepTag Non-Radioactive Protein Kinase Assay; Promega, Madison, WI, USA), according
manufacturer instructions. The PepTag® Non-Radioactive Protein Kinase Assays provide a rapid,
sensitive and non-radioactive method to detect cAMP-dependent protein kinase (PKA) and protein
kinase C (PKC) activity. The PepTag® Assays use brightly colored, fluorescent peptide substrates that
are highly specific for the kinases in question. Phosphorylation by PKC or PKA alters the peptide
substrate net charge, allowing phosphorylated and non-phosphorylated versions of the substrate to
be rapidly separated on an agarose gel. Using the PepTag® Assay, less than 10 ng of kinase can be
detected in under 2 h. Two micrograms of PepTagTMC1 peptide (PKC-specific peptide) were incubated
with the 20 µg of the protein samples in a final volume of 25 µL for 30 min at 30 ◦C. The reactions were
stopped by heating to 95 ◦C for 10 min. The samples were loaded on a 0.8% agarose gel and run at
100 Volts for 15 min. Phosphorylated peptide migrated towards the anode, while non-phosphorylated
peptide migrated towards the cathode. Intensities of charged phosphorylated bands were measured
by using a Versadoc Imaging System (Bio-Rad). Band intensity was expressed as relative absorbance
units. The positive control was run to verify the Kinase activity and results were expressed as a percent
of untreated control cells [74].
2.11. Statistical Analysis
Data are expressed as means ± S.D. of three different experiments. One-way analysis of variance
(ANOVA) followed by a post-hoc Newman-Keuls Multiple Comparison Test was used to detect
differences of means among treatments with significance defined as p < 0.05. When appropriate,
two-way ANOVA with a Bonferoni post-test was used to assess any differences among the treatments
and the times (p < 0.05). Statistical analysis was performed using GraphPad Prism version 5.00 for
Windows (GraphPad Software, San Diego California USA).
3. Results
To demonstrate the biphasic effect of RES concentrations on ROS production, HUVECs loaded with
the ROS probe H2DCF-DA were treated with different concentrations of RES (1–50 µM). As compared
to untreated cells, low RES concentration (1µM) decreases basal intracellular ROS levels, while higher
concentrations (10µM and 50µM) augment ROS levels (Figure 1C). To confirm this observation, the
variation of intracellular ROS level in response to RES was further investigated by assessing the cellular
redox state. To this end, HUVECs were transduced with the redox state sensor roGFP, which fluoresces
when oxidized, and treated with RES as indicated in the legend of Figure 1. RES at the concentration
of 1 µM exerted a significant reduction of the roGFP oxidation state as compared with ro-GFP-infected
untreated control cells, thus RES at 1 µM effectively acts as an antioxidant agent (Figure 1A,B). However,
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when roGFP-infected HUVECs were exposed to higher RES levels (50 µM), an increase of the roGFP
oxidation state was elicited (Figure 1A,B).
Accordingly, the effect of RES on HUVECs viability was tested. To this end, HUVECs were treated
with increasing concentrations (1–50 µM) of RES, and the viability of the cells was detected using the
MTT assay. Figure 2A illustrates that lower concentrations of RES (1 µM) elicited a non-significant
increase in cell viability, while higher RES concentrations (10 and 50 µM) caused a significant decrease
in cell viability, with less cell viability seen at 50 µM. To evaluate if RES has an impact on cell viability
would transpire in the context of cell proliferation, the influence of different RES concentrations on
HUVECs DNA synthesis was studied. Cells were treated with increasing concentrations of RES
(1–50 µM), then DNA synthesis was assessed using BrdU incorporation assay. At low concentrations
(1 µM), RES provoked a non-significant increase in DNA synthesis (Figure 2B). However, higher
RES concentrations (10 and 50 µM), significantly inhibited DNA synthesis, with higher inhibition
observed at 50 µM (Figure 2B). Consistent with the observed pro-oxidant effect, the increased RES
dosage elicited a corresponding decrease in both cell survival and DNA synthesis, suggesting a strong
correlation between the pro-oxidant effect and the cell damage exerted by RES. Furthermore, the
observed inhibited DNA synthesis rates under higher concentrations of RES can partially explain the
decreased cell viability with 10 and 50 µM RES.
Biomolecules 2019, 9, x FOR PEER REVIEW 9 of 23 
impact on cell viability would transpire in the context of cell proliferation, the influence of different 
RES concentrations on HUVECs DNA synthesis was studied. Cells were treated with increasing 
concentrations of RES (1–50 µM), then DNA synthesis was assessed using BrdU incorporation assay. 
At low concentrations (1 µM), RES provoked a non-significant increase in DNA synthesis (Figure 2B). 
However, higher RES concentrations (10 and 50 µM), significantly inhibited DNA synthesis, with 
higher inhibition observed at 50 µM (Figure 2B). Consistent with the observed pro-oxidant effect, the 
increased RES dosage elicited a corresponding decrease in both cell survival and DNA synthesis, 
suggesting a strong correlation between the pro-oxidant effect and the cell damage exerted by RES. 
Furthermore, the observed inhibited DNA synthesis rates under higher concentrations of RES can 
partially explain the decreased cell viability with 10 and 50 µM RES. 
Increased generation of ROS usually culminates in apoptotic cell death. An increased apoptosis 
rate can also contribute to he d creased c ll v ability seen with high RES co centrations. In o der to 
determine if lower cell viability under high RES concentrations is solely due to inhibited cell 
proliferation, apoptosis levels were compared under varying RES concentrations. The degree of DNA 
fragmentation in HUVECs exposed to increasing concentrations of RES, reflective of apoptosis levels, 
was determined. As shown in Figure 2C, lower RES concentrations exhibit no differences in DNA 
fragmentation as compared to control untreated HUVECs, on the other hand, higher concentrations 
of RES (10 and 50 µM), show significantly increased DNA fragmentation, especially at 50 µM RES. 
The results obtained in Figure 2, indicate that the lower cell viability observed using higher RES 
concentrations is due to both an anti-proliferative effect and a pro-apoptotic effect exerted by high 
concentrations of RES o  HUVECs. These results may also indicate that the anti-proliferative effect 
of high concentrations of RES may be correlated with the facilitation of an apoptotic program. 
 
Figure 2. Resveratrol concentration-dependently affect HUVECs survival, DNA synthesis, and 
apoptosis. (A) Sub-confluent HUVECs were grown for 24 h in M199 medium with 5% FCS, containing 
the indicated concentrations of resveratrol. Subsequently, cells were assessed for the viability as 
reported in materials and methods. (B) Sub-confluent HUVECs were grown for 24 h in M199 medium 
Cell viability
Resveratrol
% 
of
 co
nt
ro
l
ctrl 1 µM 10 µM 50 µM
0
50
100
150
*
*
A
DNA synthesis
Resveratrol
% 
of
 co
nt
ro
l
ctrl 1 µM 10 µM 50 µM
0
50
100
150
*
*
B
DNA fragmentation
Resveratrol
% 
of
 co
nt
ro
l
ctrl 1 µM 10 µM 50 µM
0
50
100
150
200
250
*
*
C
Figure 2. Resveratrol c n e tration-dependently affe t Cs survival, DNA synthesis, and
apoptosis. (A) Sub-confluent HUVECs were grown for 24 h i edium with 5% FCS, co taining
the indicated concentrations of resveratrol. Subsequently, cells were ass ssed for the viability as reported
in materials and ethods. (B) Sub-confluent HUVECs were gro n for 24 h in M199 medium with 5%
FCS, containing the indicated concentrations of resveratrol. Subsequently, cells were assessed for the
DNA synthesis as reported in material and methods. (C) Sub-confluent HUVECs were grown for 24 h in
M199 medium with 5% FCS, containing the indicated concentrations of Resveratrol. Subsequently, cells
were assessed for the DNA fragmentation as reported in materias and methods. ctrl: untreated cells.
Data represent means ± SDs of a representative experiment, performed in triplicates. *, significantly
different from the control (p < 0.01).
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Increased generation of ROS usually culminates in apoptotic cell death. An increased apoptosis
rate can also contribute to the decreased cell viability seen with high RES concentrations. In order
to determine if lower cell viability under high RES concentrations is solely due to inhibited cell
proliferation, apoptosis levels were compared under varying RES concentrations. The degree of DNA
fragmentation in HUVECs exposed to increasing concentrations of RES, reflective of apoptosis levels,
was determined. As shown in Figure 2C, lower RES concentrations exhibit no differences in DNA
fragmentation as compared to control untreated HUVECs, on the other hand, higher concentrations
of RES (10 and 50 µM), show significantly increased DNA fragmentation, especially at 50 µM RES.
The results obtained in Figure 2, indicate that the lower cell viability observed using higher RES
concentrations is due to both an anti-proliferative effect and a pro-apoptotic effect exerted by high
concentrations of RES on HUVECs. These results may also indicate that the anti-proliferative effect of
high concentrations of RES may be correlated with the facilitation of an apoptotic program.
To gain molecular insight into the mechanism of high concentration RES induced apoptosis,
we quantified the mRNA levels of the anti-apoptotic gene, Bcl-2, and the pro-apoptotic gene, Bax.
To this end, HUVECs were treated with 1 µM, 10 µM, and 50 µM of RES and RT-PCR was performed
to determine the expression levels of both genes. As shown in Figure 3B, the concentration of
1 µM RES significantly increased Bcl-2 mRNA levels, which could explain the increased viability
of HUVECs obtained at the same concentration (Figure 2). As compared to control cells, higher
RES concentrations significantly diminished Bcl-2 mRNA levels, reaching the highest decrease at
50 µM (Figure 3B). A different effect was exerted by RES on Bax, which showed a low expression at
lower RES concentration (1 µM), while its mRNA levels spiked at higher RES concentrations (50 µM)
(Figure 3C). Figure 3, which illustrates and compares Bax and Bcl-2 gene expression under different RES
concentrations, confirms the role RES plays in the induction of cellular apoptosis observed with higher
RES concentrations and further attests to the biphasic effect exerted by different RES concentrations.
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Figure 3. igh concentrations of RES odulate gene expression of apoptotic genes. ECs gro n
in 199 ediu ith 5 FCS ere sti ulated for 40 in ith different concentrations of RES as
indicated. (A) Representative agarose electrophoretic gel reporting the PCR product size in base pairs
for Bax 291; Bcl-2 460 and GAPDH 598. PCR product semiquantitative analysis for the Bcl-2 (B) and Bax
(C) in HUVECs treated as described. ctrl: untreated cells. Values are Means ± SD of a representative
experiment, performed in triplicates. *, significantly different from the control (p < 0.01).
For a more molecular characterization of the RES induced inhibition of DNA synthesis observed
in Figure 2, gene expression of c-myc and ODC was studied by RT-PCR. c-myc and ODC are genes
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that play pivotal roles in cell cycle progression and cell proliferation and are tightly controlled
throughout the cell cycle. RT-PCR of c-myc and ODC was performed on total RNA from HUVECs
treated with increasing concentrations of RES. c-myc gene expression was significantly increased by
1 µM RES treatment, and ODC gene expression was also increased by the same treatment although
non-significantly (Figure 4A,B). These data further corroborate and explain the results obtained in
Figure 3, showing a low concentration of RES activating the antiapoptotic gene Bcl-2. Figure 4 also
indicates that higher concentrations of RES (10 and 50 µM) significantly decreased the mRNA levels of
the prosurvival genes c-myc and ODC. Again, these data go hand in hand with the cell survival data
obtained in Figure 2. RES, also, has a dichotomous effect on gene expression of c-myc and ODC.
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Figure 4. High concentrations of RES modulate gene expression of prosurvival genes. HUVECs grown
in M199 mediu with 5% FCS were stimulated for 40 min with different concentrations f RES as
indicated. (A) Representative agarose electrophoretic gel reporting the PCR product size in base pairs
for c-myc 479; ODC 120 and GAPDH 598. PCR product semiquantitative analysis for the c-myc (B)
and ODC (C) in HUVECs treated as described. ctrl: untreated cells. Values are Means ± SD of a
representative experiment, performed in triplicates. *, significantly different from the control (p < 0.01).
Among the investigated genes affected by RES, c-myc and Bcl-2 are reported to be essential
regulators of cell cycle progression, an effect at least in part mediated by their interaction with the
cell cycle regulator protein cyclin D1 from G0/G1 to S phase [75–78]. That given, we further dissected
the effect of RES on cell proliferation by investigating the effect of different RES concentrations on
HUVECs cell cycle progression machinery. Data in Figure 5A clearly indicate that a high concentration
of RES blocked HUVECs cell cycle progression by prompting their accumulation in the G0/G1 or S
phase depending on the dosage. Cyclin D1 protein expression was assessed, since it controls G0/G1
to S phase transition, by western blotting. As shown in Figure 5B,C, at a lower concentration of RES
(1 µM) there is no difference in cyclin D1 protein levels as compared to control cells, but at higher
concentrations (10 and 50 µM), RES significantly inhibits cyclin D1 protein expression. This finding
strongly supports the hypothesis that RES, by modulating c-myc and Bcl-2 expression, may suppress
HUVECs proliferation by downregulating cyclin D1 expression ultimately arresting the cells in G0/S
phases of the cell cycle. Moreover, the observed decrease in cyclin D1 protein levels also corroborates
to the low cell viability observed in Figure 2 and further confirm the biphasic effect of RES on essential
genes involved cell cycle progression and apoptosis.
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( ) Sub-confluent HUVECs were grown for 48 h in M199 mediu with 5% FCS, containing the indicated
concentrations of resveratrol. Subsequently, cells were assessed for their cell cycle distribution as
reported in materials and methods. (B,C) Sub-confluent HUVECs grown in M199 medium containing
5% FCS were stimulated for 12 hrs with different concentrations of RES as indicated. (B) Representative
immunoblot of cyclin D and β-actin of HUVECs treated with different RES concentrations. (C) The
graph represents the immunodensity quantitative analysis of three different immunoblot experiments.
ctrl: untreated cells. Mean ± SD values of a representative experiment, performed in triplicates, are
shown. *, significantly different from the control (p < 0.01).
We have previously reported that RES affects HUVECs survival by eliciting Flavin-oxidase
mediated ROS generation which in turn inhibits Akt activation ultimately prompting cell death by
apoptosis [43]. However, we have no clue concerning the fact that ROS generation, in RES-induced
endothelial cells, may act on enzymes upstream of Akt such as PKC for one instance [79,80]. In this
regard, a bidirectional link has been proposed between PKC activation and ROS generation in different
cell type including endothelial cells [17,28,30,35,36]. We hypothesized that RES-induced ROS generation
might biphasically modulates PKC activity, leading to the activation of pro- or anti-survival machinery
depending on the RES dosage. To address this hypothesis, we assessed the activity of PKC in HUVECs
treated with different RES concentrations in the absence or presence of the ROS scavenger Tempol.
Figure 6A illustrates that RES at low concentrations (1 µM) enhances PKC activity, while at higher
RES concentrations (25 and 50 µM), PKC activity is abrogated, clearly indicating that different RES
concentrations exert a biphasic effect on PKC activation.
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Figure 6. (A) RES generated ROS biphasically modulates PKC activity. HUVECs were grown in M199
medium containing 5% FCS and then treated for 40 min with the indicated concentrations of RES
and then PKC activity was measured as described in the materials and methods section. (B) Same
as in A, but in the absence or presence of Tempol. HUVECs were pre-treated or not for 1 hr with
the ROS scavenger Tempol (100 µM). PKC activities are expressed as % of control (ctrl). (+): positive
control of PKC activation (phosphatidylserine 0.2 mg/mL). Means ± SDs of a representative experiment,
performed in triplicates, are shown. *, significantly different from the control (p < 0.01).
To test the involvement of ROS in the RES biphasic activation of PKC, different RES concentrations
were used to modulate PKC activity in the presence and absence of the ROS scavenger Tempol [81–83].
Comparing the effect of low concentration RES (1 µM) in the presence and absence of Tempol, it can be
seen that, the scavenger action of Tempol reverses the increased PKC activation elicited by low RES
concentration (Figure 6B). The same figure also shows that at high RES concentrations (50 µM), PKC
activity is diminished, but this RES effect is abolished when cells are pre-treated with Tempol. These
data strongly indicate that the biphasic effect of RES on PKCs activation is dependent on the level of
generated ROS.
If the effect of RES on PKC is mediated by ROS it is reasonable to hypothesize that both ROS and
PKC could be involved in modulating the expression of c-myc and Bcl-2, ultimately defining the cell
fate based on the RES dosage. Therefore, by using a broad flavin oxidase inhibitor, DPI, and a broad
PKC inhibitor, CHE, we tested whether flavin oxidase-mediated ROS generation and PKC activation
are involved in modulating c-myc and Bcl-2 protein expression and thus HUVECs proliferation in
response to RES treatment. As reported in Figure 7, both DPI and CHE were able to abrogate the
biphasic effect of RES on c-myc and Bcl-2 gene expression and HUVECs proliferation. These data
strongly implicate these two enzymes in the cellular response to different RES dosages.
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4. Discussion
Resveratrol, 3,5,4′ trihydroxystilbene, is a phytoalexin that is naturally produced by plants
in response to infection. This naturally occurring compound possesses antioxidant beneficial
cardioprotective, anti-cancerous and anti-inflammatory properties [84]. However, the effects of
resveratrol have been mainly tested against oxidative stress-induced damage or other toxic insults,
whereas relatively few studies have been performed to understand RES potential effects under normal
conditions. For example, RES at a concentration of 50 µM, a dosage that under our current experimental
conditions induces HUVEC damage, protects cardiomyocytes against anoxia/reoxygenation-elicited
impairment [85] and protects HUVECs from ox-LDL-induced oxidative damage [86]. In this regard,
it has been suggested that RES can work as a pro-oxidant under low redox conditions, while it acts
as an antioxidant under highly oxidative conditions [49,87]. Such behavior has been reported for
other natural antioxidants in different experimental models [88], suggesting that the interaction of
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exogenous antioxidants depends on the cellular redox state, and is essential especially when precise
redox modulation is needed to determinate whether the final cell fate is survival or death. Previous
reports have shown that RES, at low concentrations, acts as an antioxidant; however, at higher
concentrations, it becomes a pro-oxidant that increases ROS generation and initiates apoptosis and cell
senescence [89]. In endothelial cells with low oxidative stress, high RES concentrations are harmful
rather than beneficial [49]. RES may act as an anti-oxidant and scavenges the low levels of ROS,
which are required for ROS physiological signalling. Under these conditions, the antioxidant effects of
RES are not needed, and the cell eliminates RES using the anti-xenobiotic metabolic pathway which
generates high ROS levels [46]. We have previously demonstrated that ROS generation leads to
mitochondria-dependent apoptotic cell death [46]. In fact, RES, at high concentrations, caused cell
damage through CYP-mediated increase of ROS levels. CYP2C9, involved in xenobiotic metabolism
and a key source of intracellular ROS, metabolizes RES producing excessive ROS levels. In addition,
drugs, toxins or pathological conditions that increase ROS production promote the loss of mitochondrial
membrane potential (MMP), leading to cell death. Treatment of cells with high concentrations of RES
and CsA, a mitochondrial permeability transition pore inhibitor, prevented MMP and cell death by
ROS, linking high levels of RES to mitochondrial damage and mitochondrial induced cell death [46].
This biphasic RES concentration effect is further supported by Pasciu et al. who showed that
instead of counteracting ROS effect on endothelial cells, RES actually induced ROS production [43].
Furthermore, prolonged RES exposure leads to senescence and cell cycle arrest due to increased and
prolonged ROS production [90]. Indeed, the biphasic RES concentration effect on ROS production has
been demonstrated by us and others [43,45–48,63]. In this work, we further dissected at a molecular
level this RES functional dichotomy on ROS production, where high levels of RES induced ROS
production and produced an oxidized cell-redox state and low RES concentrations inhibited ROS
generation. This biphasic RES effect on ROS production transpired into a biphasic RES effect on
apoptotic rate, DNA synthesis, and PKC activity in HUVECs. In fact, high RES levels enhanced
apoptosis, inhibited DNA synthesis, and inhibited PKC activity in HUVECS, while low RES dosage
inhibited apoptosis, enhanced DNA synthesis, and increased PKC activity in HUVECs. These data
show that RES functional dichotomy affects cell physiology differently, where cell survival is enhanced
at low RES levels and suppressed at high RES levels.
The molecular mechanisms by which RES can biphasically act on endothelial cells and induce
apoptosis are still controversial and undefined. This work was undertaken to investigate these
molecular mechanisms and gain more understanding concerning the impact of RES on HUVECs.
In this respect, we found that lower RES concentrations of 1 µM, increase DNA synthesis and expression
of genes involved in cell cycle regulation (c-myc, ODC, and cyclin D1) and inhibits apoptosis and
decreases the expression of pro-apoptotic genes (Bax) and increases the expression of anti-apoptotic
genes (Bcl-2). However, at higher concentrations (10 and 50 µM), RES enhances apoptosis and
pro-apoptotic Bax gene expression and decreases DNA synthesis and the expression of c-myc, ODC,
cyclin-D1, and the anti-apoptotic Bcl-2 gene. The dichotomous effect of RES on Bcl-2 and Bax expression
is consistent with the biphasic RES modulation of ROS, and thereafter modulation of apoptosis. Bcl-2
and Bax regulate apoptosis at the level of the mitochondria [91], here we find these new data to further
support our previous report that high RES concentrations do induce high ROS levels that then elicit
mitochondrial induced cell death [46]. In fact, Bax acts by creating pores in the mitochondrial outer
membrane which then leads to the release of mitochondrial intermembrane space proteins such as
cytochrome-c and disruption of MMP [91]. This role of Bax is also consistent with our previous work
in which we show that high RES concentrations modulate MMP [46]. Nevertheless, it should be
mentioned that Bax activation can also contribute to ROS generation [91], so there remains the testable
possibility that RES activates Bax which then initiates apoptosis and ROS generation. As we only have
data concerning Bcl-2, future work should focus if RES biphasically also affects Bax at the translational
levels and if there is a biphasic modulation of downstream mediators of mitochondrial-induced
apoptosis such as the release of cytochrome-c and the consequent activation of PARP and effector
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caspases. Above all, future research should address if Bcl-2 and Bax are required at all for MMP
alteration and the execution of the cell death program initiated by high RES concentrations.
c-myc regulates the transition from G0 to S phase in the cell cycle, and ODC can act at G1/S,
S/G2 and G2/M cell cycle transition [24]. Noteworthy, c-myc over expression activates ODC which
then promotes cell growth [25]. At the same time, c-myc is known to have pro and anti-apoptotic
roles [22]. In addition, there is a bidirectional interplay between c-myc and ROS. c-myc overexpression
can upregulate ROS production [23], and ROS can inhibit c-myc expression [12]. Interestingly, c-myc
downregulation is a pre-requisite for ROS induced apoptosis in M14 human melanoma cells [92],
which is evident in the current study where high RES concentrations have downregulated both c-myc
mRNA levels and protein expression and increased apoptosis. More importantly, both Bcl-2 and c-myc
are an essential regulator of cell cycle progression, an effect at least in part mediated by their interaction
with the cell cycle regulator protein cyclin D1. In fact, while Bcl-2 overexpression induces cyclin D1
promoter activity, its silencing exerts a decrease in cyclin D1 expression [75,76]. On the other hand,
c-myc has been proposed as one of the main drivers in promoting Cyclin D1 expression by linking
mitogen-stimulated signal transduction to the cell cycle [77,78]. Consonant with what is discussed
above are our data in Figure 5, showing the downregulation of cyclin D1 paralleled by the cell cycle
arrest in G0/S phase. Summation of all the previous discussion makes us envisage molecular pathways
for the biphasic action of RES.
A possible pathway is that at high RES concentrations, xenobiotic metabolism of RES by CYP2C9
leads to elevated ROS generation, which then induces a change in c-myc and Bcl-2 levels that then,
by affecting Cyclin D1 expression, modulate cell cycle progression and apoptosis. Of course, c-myc
down-regulation can be a cause or a result of high ROS levels, but this remains to be determined. High
ROS levels, in the presence of low c-myc levels, can also alter MMP (probably through Bax) leading to
mitochondrial activation of apoptosis. In this scenario, Bax also can be acting upstream or down stream
of ROS, and this again remains to be determined. Although an inhibitory effect of RES on PKC has been
reported in adenocarcinoma cells [93], we show for the first time that RES has a biphasic concentration
effect on PKC activation in normal human endothelial cells and demonstrated the implication of ROS in
its mediation. Higher concentrations of RES downregulate PKC activity, while low RES concentrations
enhanced PKC activity (Figure 6A). In this regard, we believe that ROS can both activate or inhibit PKC
depending on ROS localization, source, and concentration [94,95]. Indeed, high RES concentrations
can induce high levels of ROS that inhibit PKC, while low RES concentrations generate lower levels
of ROS that elicit, instead, the activation of PKC (Figure 6A). This biphasic effect of RES appears to
be dependent on ROS levels since the addition of a ROS scavenger, Tempol, ablated it (Figure 6B).
In fact, on one hand, Tempol is able to abrogate the PKC inhibition elicited by the high levels of ROS
produced by 50 µM RES. On the other hand, Tempol suppresses PKC activity induced by low levels of
ROS, which in turn are produced by low RES concentrations. (Figure 6B). Here we can see an interplay
between ROS and PKC. Consistently, many studies have reported that there is a bidirectional crosstalk
between ROS and PKC activation [28,30,96–102]. Figure 6B also points to the fact that ROS production
precedes PKC action and it maybe the point connecting ROS-generating flavin oxidases enzymes such
as CYP2C9 or NOX with the cell cycle machinery. In fact, failure of RES to induce its biphasic effect in
the presence of the flavin inhibitor DPI implicated flavin oxidase-generated ROS as the mechanistic link
between RES and the cell cycle machinery (Figure 7A). The same figure also indicates the involvement
of PKC in the RES effect upon cell cycle regulatory genes and HUVECs viability as pointed out by
the ability the PKC inhibitor CHE to significantly abrogate them. The findings reported in Figure 6B,
along with those of Figure 7 suggest that PKC may be located downstream CYP2C9 and/or NOX and
being modulated biphasically based on the ROS produced by different RES dosages.
In this regard, it will be interesting to perform the reverse experiment where pan-PKC activity is
inhibited, and ROS production is monitored. This experiment will further demonstrate the bidirectional
interplay between ROS and PKC, and RES for that effect. All the above can be modeled into a signaling
pathway where high RES concentrations increase ROS production that activate PKC which then
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triggers a pathway that down-regulates the genes and proteins involved in cell proliferation (c-myc,
ODC, and cyclin D1) and that abrogates genes and proteins involved in cell apoptosis (Bax and
Bcl-2), thus inducing a cell cycle arrest and initiating mitochondrial apoptosis as discussed above.
The reverse can take place at low RES levels, leading to enhanced cell survival and lower apoptotic
cell death. In this pathway, ROS signaling to PKC could be dependent on NOXs activation since
NADPH oxidases rather than CYPs are more likely involved in the signaling between ROS and
PKC [28,98]. In this regard, micromolar concentrations of RES (0,1–0,5 µM) have been reported to
activate Akt, increase NO production and inhibit NADPH oxidase-dependent ROS generation in
human platelets [103], which seems a common property possessed by others NA such as quercetin and
red wine polyphenols [104,105]. Although the above data are strongly consistent with our present
results, testing this notion under our experimental conditions, require specific NOXs inhibitors or
knockdown experiments to better dissect the cellular source of ROS modulated by different RES
concentrations. This functional dichotomy is not a property of RES per se but is intimately tied
to a general ROS signaling mechanism. For instance, physiologic production of ROS is known to
activate the JAK/STAT pathway, while dramatically increased ROS cause its inhibition [9]. Similarly,
physiological levels of ROS promote cell survival under hypoxic/ischemic conditions, but higher levels
can precipitate cell death via apoptotic or autophagic pathways [9].
It remains to be determined, whether the concentration-dependent effect of RES always involves
ROS generation as a general biological process, or other molecular pathways are implicated [89,106].
For instance, RES inhibits adipocyte differentiation and induces apoptosis in pre-adipocytes and
mature adipocytes at concentrations beyond 20 µM [107–109], while RES works as an antidiabetic
drug promoting glucose uptake in the range of 0.01–1 µM [110]. RES-also elicited pro- and anti-fibroti
responses of human tubular epithelial cell in vitro, and in mice kidneys in vivo are dependent on the
RES concentration employed [111]. Although many RES-elicited responses, including some of those
mentioned above, are mediated by sirtuins [108–110,112,113], a link between ROS, Sirtuin and RES has
been reported only during its protective action in oxidative-induced experimental models [114–116].
Future studies should address if such a link exists between RES, sirtuins and ROS generation in
HUVECs and other types of cells under both normal and oxidative stress conditions.
The study of the negative impact of high RES concentrations on endothelial cell function should
be further investigated to more deeply dissect the molecular underpinnings behind high dosage
effects, both in vitro and in vivo. Moreover, the public should be made aware that antioxidants
supplementation is still an area of investigation, and that potential health benefits can be attained only
at specific natural antioxidants dosages that are yet to be identified.
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